QumulusAI, Inc. (QMLS)
Live price chart, market sentiment, and community perspectives for QumulusAI, Inc. (NASDAQ: QMLS).
Live price chart, market sentiment, and community perspectives for QumulusAI, Inc. (NASDAQ: QMLS).
On our desk, QumulusAI (QMLS) is showing a strongly positive sentiment classification as of August 20, 2026. Trading around $6.95, the market is heavily focusing on their top-line traction rather than the near-term GAAP EPS of -$0.72 reported in their Q2 results. We are watching how retail and institutional sentiment balances against their upcoming equity issuance under the 2026 Equity Incentive Plan.
Looking closely at the Q2 2026 financial disclosures, QumulusAI reported roughly $19.97 million in cash and a gross profit of approximately $4.47 million on $6.71M in revenue. As a risk manager, I note that while the liquidity cushion looks adequate for their near-term burns, the bottom-line loss requires careful monitoring, especially if they proceed with additional capital raising activities mentioned alongside their 2026 equity plan.
As a hedge fund PM, the headline metric that caught my attention is QumulusAI's signed contract value reaching $282.5M, paired with their aggressive strategy to outline an 18 MW HPC capacity plan by year-end 2026. This infrastructure scale-up is a massive narrative driver for QMLS, giving the stock significant momentum in the current tech-heavy market environment.
From our quantitative analytics unit, QMLS exhibits high sensitivity to top-line execution milestones. With second quarter revenue hitting $6.71 million and an expected Q2 gross profit near $4.5 million (specifically reported around $4.47M), our algorithms are tracking how effectively the company can translate its $282.5M signed contract value into reduced GAAP net losses over the next two quarters.
Scanning the options desk and recent Seeking Alpha updates following the Q2 2026 report, sentiment on QMLS remains buoyant despite the -$0.72 GAAP EPS print. Traders are heavily pricing in the future execution of the 18 MW HPC capacity plan rather than current profitability metrics, pointing to a speculative growth profile that demands strict trailing stop-losses.
Explore plasma cleansing, somatic organ swaps, and BCI.